Current
and the
(U54MD017979-5479) Full Project 2024-2029. “Nanoparticle-targeted therapeutic development for glomerular diseases.” With Kirk Campbell and Jenny Wong (UPenn) and Edgar Jaimes (MSKCC). PI: 2026-2029 Steve Nicoll, CCNY
Maximizing Investigators’ Research Award Early Stage Investigator (MIRA ESI) (R35GM142833), 2021-2026. “Investigating real-time multi-system cytokine signaling in chronic disease.”
(T32GM136499), 2024-2027. Trainee Atara Israel.
Completed
. 2022-2025 “Injectable hydrogel-nanomaterial composites for local delivery and detection of doxorubicin for the treatment of triple negative breast cancer.” With Steve Nicoll (CCNY) and Hanna Irie (Icahn School of Medicine at Mount Sinai).
(T32GM136499), 2021-2024. Trainee Amelia Ryan.
(R35GM142833-03S2), 2023-2024. Equipment Supplement to purchase an IMA Near-Infrared Hyperspectral Microscope.
(R35GM142833-02S1), 2022-2024. Trainee Atara Israel.
(5U54CA137788-12) Full Project, 2022-2024. “Targeting onconephrology with gene-regulating nanomedicine.” PI with Edgar Jaimes (MSKCC).
(5U54CA137788-12) Supplement Award, 2023. “Reactive oxygen species as a therapeutic target in onconephrology.” PI with Edgar Jaimes (MSKCC).
, 2022-2023. “Early non-invasive in vivo detection of atherosclerosis.” Trainee Pooja Gaikwad.
2021-2022. “Design of fluorescent nanosensors for bedside detection of inflammatory proteins.” PI with Tai-De Li and Tong Wang (ASRC).
Ralph E. Powe Junior Faculty Enhancement Award, 2021-2022. “Renal targeted siRNA therapy to treat acute kidney injury.”
(5U54CA137788-12) Pre-Pilot Award, 2021. “Rapid diagnostic evaluation of estrogen receptor status in fine needle aspiration biopsies.” PI with Dianna Ng (MSKCC).
Enhanced Award Cycle 52, 2021-2022. “Rapid, label-free bedside detection of viral-associated cytokine storm.”
(5U54CA137788-12) Pre-Pilot Award, 2020. “Nanocomposite hydrogels for detection and preventative therapy for breast cancer.” PI with Steve Nicoll (CCNY) and Mark Robson (MSKCC).
Enhanced Award Cycle 51, 2020-2021. “Design of a novel targeted nanotherapeutic to treat chronic kidney disease.”
, ,